Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07146139 · ClinicalTrials.gov registry record · NA
MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transgender Women
A NA study, sponsored by Public Health Foundation Enterprises.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT07146139: Clinical Trial NA study, sponsored by Public Health Foundation Enterprises.
NCT07146139 is a NA study that was terminated before completion, run by Public Health Foundation Enterprises. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07146139, a NA study, was terminated before completion, sponsored by Public Health Foundation Enterprises.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The primary goal of this randomized controlled trial is to learn if a decision support tool called MyPrEP Plus can help transgender women make decisions about taking pre-exposure prophylaxis (PrEP) for HIV prevention.
Primary Outcome
Participant responses to the Client Satisfaction Questionnaire (CSQ-8) and the System Usability Scale (SUS) assessment tools which assess the various domains of the combined tools will be used to evaluate the acceptability of the MyPrEP Plus package. Scores for the CSQ-8 and the SUS range from 8-32 and 0-100, respectively with higher scores representing greater satisfaction and usability. Web-based analytics of the MyPrEP website combined with responses within the PrEPmate tool and time spent us
Interventions
- BEHAVIORAL Standard of Care (SOC)
- DEVICE MyPrEP Plus Package
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-03-18 |
| Est. Completion | 2025-03-21 |
| Phase | NA |
Why NCT07146139 stopped before completion
NCT07146139 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care (SOC) is the first listed.
NCT07146139 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07146139 about?
NCT07146139 is a clinical study titled "MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transgender Women". The primary goal of this randomized controlled trial is to learn if a decision support tool called MyPrEP Plus can help transgender women make decisions about taking pre-exposure prophylaxis (PrEP) for HIV prevention.
What is the current status of trial NCT07146139?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2023-03-18. Estimated completion is 2025-03-21.
What interventions are being tested in trial NCT07146139?
The interventions under investigation include: Standard of Care (SOC) (BEHAVIORAL), MyPrEP Plus Package (DEVICE).
Who is sponsoring clinical trial NCT07146139?
This trial is sponsored by Public Health Foundation Enterprises, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07146139's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI